Market revenue in 2023 | USD 30.9 million |
Market revenue in 2030 | USD 40.5 million |
Growth rate | 3.9% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Ex-Vivo Organ Perfusion System |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 43.69% in 2023. Horizon Databook has segmented the Sweden perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
The perfusion system market in Sweden is growing due to the availability of advanced products developed by key companies and the rising prevalence of chronic diseases, which can cause respiratory failure and require medical attention.
Moreover, Sweden’s strong interest in adopting innovative medical technologies and its focus on progressive healthcare solutions have heightened the demand for state-of-the-art perfusion systems. Furthermore, the growth of Sweden’s perfusion systems market can be attributed to several key factors, including the increasing geriatric population.
The geriatric population has steadily grown, increasing from 14.5% in 1973 to 20.2% in 2022, with an average annual growth rate of 0.69%. The rapidly growing geriatric population is at a higher risk of chronic diseases, driving the demand for perfusion systems.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into Sweden perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account